Page 884 - Clinical Immunology_ Principles and Practice ( PDFDrive )

856 Part Seven Organ-Specific Inflammatory Disease

34. Husebekk A, Killie MK, Kjeldsen-Kragh J, et al. Is it time to implement 45. Olson B, Anderson PO, Jernas M, et al. T-cell mediated cytotoxicity
HPA-1 screening in pregnancy? Curr Opin Hematol 2009;16:497–502. toward platelets in chronic idiopathic thrombocytopenic purpura. Nat
35. Vinograd CA, Bussel JB. Antenatal treatment of fetal alloimmune Med 2003;9:1123–4.
thrombocytopenia: a current perspective. Haematologica 46. Panitsas FP, Theodoropoulou M, Kouraklis A, et al. Adult chronic
2010;95:1807–11. idiopathic thrombocytopenic purpura (ITP) is the manifestation of a
36. Kiefel V, Konig C, Kroll H, et al. Platelet antibodies in transfused patients. type-1 polarized immune response. Blood 2004;103:2645–7.
Transfusion 2001;41:766–70. 47. Yu J, Heck S, Patel V, et al. Defective circulating CD25 regulatory T cells
37. George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, in patients with chronic immune thrombocytopenic purpura. Blood
evaluation, and management. Hematology Am Soc Hematol Educ 2008;112:1325–8.
Program 2009;153–8. 48. Emmerich F, Bal G, Barakat A, et al. High-level serum B-cell activating
38. Aster RH, Curtis BR, McFarland JG, et al. Drug-induced immune factor and promoter polymorphisms in patients with idiopathic
thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb thrombocytopenic purport. Br J Haematol 2007;136:309–14.
Haemost 2009;7:911–18. 49. Olson B, Ridell B, Carlsson L, et al. Recruitment of T cells in the bone
39. Otis SA, Zehnder JL. Heparin-induced thrombocytopenia: current status marrow of ITP patients possibly due to elevated expression of VLA-4 and
and diagnostic challenges. Am J Hematol 2010;85:700–6. CX3CR1. Blood 2008;112:1078–84.
40. Takahashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by 50. McMillan R, Wang L, Tomer A, et al. Suppression of in vitro
Helicobacter pylori CagA protein may be involved in the pathogenesis of megakaryocytic production by antiplatelet autoantibodies from adult
H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J patients with chronic ITP. Blood 2004;103:1364–9.
Haematol 2004;124:91–6. 51. Aledort LM, Hayward CP, Chen MG, et al. Prospective screening of 205
41. Arnold DM, Bernotas A, Nazi I, et al. Platelet count response to H. pylori patients with ITP, including diagnosis, serological markers, and the
treatment in patients with immune thrombocytopenic purpura with and relationship between platelet counts, endogenous thrombopoietin, and
without H. pylori infection: a systematic review. Haematologica circulating anti-thrombopoietin antibodies. Am J Hematol
2009;94:850–6. 2004;76:205–13.
42. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic 52. Provan D, Stasi R, Newland AC, et al. International consensus report on
thrombocytopenic purpura: assessing the risks for the infant at delivery. the investigation and management of primary immune
Obstet Gynecol Surv 1993;48:781–8. thrombocytopenia. Blood 2010;115:168–86.
43. West KA, Anderson DR, McAlister VC, et al. Alloimmune 53. Vesely SK, Perdue JJ, Rizvi MA, et al. Management of adult patients with
thrombocytopenia after organ transplantation. N Engl J Med persistent idiopathic thrombocytopenic purpura following splenectomy: a
1999;341:1504–7. systematic review. Ann Intern Med 2004;140:112–20.
44. McMillan R. Antiplatelet antibodies in chronic adult immune 54. Yu X, Menard L, Prechl J, et al. Monovalent Fc receptor blockade by an
thrombocytopenic purpura: assays and epitopes. J Pediatr Hematol Oncol anti–Fcγ receptor/albumin fusion protein ameliorates murine ITP with
2003;25:S57–61. abrogated toxicity. Blood 2016;127:132–8.